Vertex Founder Joshua Boger to Receive MassBio’s Henri Termeer Innovative Leadership Award
March 12, 2012
Commitment to innovation, growth, and leadership in Massachusetts
March 12, 2012 (CAMBRIDGE, MA) – Joshua Boger, Ph.D., will be honored for his commitment and contributions to the biotechnology industry, the Massachusetts Biotechnology Council (MassBio) announced today.
Dr. Boger founded Vertex Pharmaceuticals Incorporated in 1989, served as the company’s CEO from 1992 to May 2009 and continues to serve on Vertex’s Board of Directors.. Under Dr. Boger’s leadership, Vertex grew from its initial handful of scientists in one Cambridge laboratory to more than 1,300 employees across research and development sites in the U.S., Canada and United Kingdom. Today, Vertex employs more than 2,000 people worldwide, including approximately 1,400 in Massachusetts.
Dr. Boger is also board member to organizations such as Harvard Medical School, Network for Healthcare Innovation, and the Museum of Science. His continued commitment to the Massachusetts biotech industry and his leadership in the field has helped to build Massachusetts as a world-leader in life sciences.
“Joshua Boger is well known as an industry leader in Massachusetts, and his commitment to developing new medicines aimed at treating serious diseases in entirely new ways is nearly unparalleled,” said MassBio President & CEO Robert K. Coughlin. “We are thrilled to honor that, and also Josh’s commitment to being a civic leader, champion of science education and advocate for patients around the world.”
The award will be presented at MassBio’s Annual Meeting on Tuesday, March 27th at the Royal Sonesta Hotel, 40 Edwin Land Blvd, Cambridge, MA. The two-day MassBio Annual Meeting will feature panel discussions, poster presentations and keynotes, including talks by Stephen Spielberg, Deputy Commissioner for Medical Products and Tobacco, U.S. FDA, and Francis S. Collins, Director, National Institutes of Health. The full meeting agenda is attached or available online.
The award, now name the Henri Termeer Innovative Leadership Award, recognizes an industry executive who has a strong presence and commitment to growth in Massachusetts, actively supports community-based organizations, contributes to science education to prepare the future workforce, and creates a positive work environment that fosters motivation and collaboration.
Henri Termeer was President and CEO of Genzyme for nearly thirty years. Under his leadership, Genzyme grew to become one of the world’s leading biotechnology companies. He is well known for his contributions to the biotech industry and has received many awards for his dedication to life sciences. Because of his commitment to the industry and to doing business in Massachusetts, MassBio chose to rename their annual award for Termeer, a true innovator and leader in biotechnology.
Boger is the fourth person to receive this award. Past recipients include former EMD Serono President & CEO Fereydoun Firouz, Cubist Pharmaceuticals President & CEO Michael Bonney, and Millennium: The Takeda Oncology Company President & CEO Deborah Dunsire.